v3.26.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Warrants
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2024   85,950,493        
Beginning balance at Dec. 31, 2024 $ (711.9) $ 0.9 $ 825.4 $ 7.8 $ (1,539.0) $ (7.0)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Other comprehensive income 0.0          
Net loss (309.9)       (309.9)  
Settlement of tax withholdings on equity-based incentive compensation (6.5)   (6.5)      
Settlement of restricted stock units (in shares)   708,920        
Settlement of restricted stock units 18.6   18.6      
Ending balance (in shares) at Jun. 30, 2025   86,659,413        
Ending balance at Jun. 30, 2025 (1,009.7) $ 0.9 837.5 7.8 (1,848.9) (7.0)
Beginning balance (in shares) at Mar. 31, 2025   86,621,470        
Beginning balance at Mar. 31, 2025 (862.3) $ 0.9 837.0 7.8 (1,701.0) (7.0)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Other comprehensive income 0.0          
Net loss (147.9)       (147.9)  
Settlement of tax withholdings on equity-based incentive compensation (0.1)   (0.1)      
Settlement of restricted stock units (in shares)   37,943        
Settlement of restricted stock units 0.6   0.6      
Ending balance (in shares) at Jun. 30, 2025   86,659,413        
Ending balance at Jun. 30, 2025 (1,009.7) $ 0.9 837.5 7.8 (1,848.9) (7.0)
Beginning balance (in shares) at Dec. 31, 2025   86,776,552        
Beginning balance at Dec. 31, 2025 (732.7) $ 0.9 838.8 7.8 (1,573.4) (6.8)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Other comprehensive income 0.6         0.6
Net loss (412.9)       (412.9)  
Settlement of tax withholdings on equity-based incentive compensation (6.2)   (6.2)      
Settlement of restricted stock units (in shares)   299,496        
Settlement of restricted stock units 14.1   14.1      
Exercise of warrants (in shares)   766,987        
Exercise of warrants 0.0   7.8 (7.8)    
Ending balance (in shares) at Jun. 30, 2026   87,843,035        
Ending balance at Jun. 30, 2026 (1,137.1) $ 0.9 854.5 0.0 (1,986.3) (6.2)
Beginning balance (in shares) at Mar. 31, 2026   87,040,558        
Beginning balance at Mar. 31, 2026 (1,043.2) $ 0.9 845.3 7.8 (1,890.4) (6.8)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Other comprehensive income 0.6         0.6
Net loss (95.9)       (95.9)  
Settlement of tax withholdings on equity-based incentive compensation (1.0)   (1.0)      
Settlement of restricted stock units (in shares)   35,490        
Settlement of restricted stock units 2.4   2.4      
Exercise of warrants (in shares)   766,987        
Exercise of warrants 0.0   7.8 (7.8)    
Ending balance (in shares) at Jun. 30, 2026   87,843,035        
Ending balance at Jun. 30, 2026 $ (1,137.1) $ 0.9 $ 854.5 $ 0.0 $ (1,986.3) $ (6.2)